173 related articles for article (PubMed ID: 12189171)
1. Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines.
Mohindra A; Hays LE; Phillips EN; Preston BD; Helleday T; Meuth M
Hum Mol Genet; 2002 Sep; 11(18):2189-200. PubMed ID: 12189171
[TBL] [Abstract][Full Text] [Related]
2. A tumour-derived mutant allele of XRCC2 preferentially suppresses homologous recombination at DNA replication forks.
Mohindra A; Bolderson E; Stone J; Wells M; Helleday T; Meuth M
Hum Mol Genet; 2004 Jan; 13(2):203-12. PubMed ID: 14645207
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of homologous recombination by treatment with BVDU (brivudin) or by RAD51 silencing increases chromosomal damage induced by bleomycin in mismatch repair-deficient tumour cells.
Vernole P; Muzi A; Volpi A; Dorio AS; Terrinoni A; Shah GM; Graziani G
Mutat Res; 2009 May; 664(1-2):39-47. PubMed ID: 19428379
[TBL] [Abstract][Full Text] [Related]
4. Defective DNA mismatch repair and XRCC2 mutation in uterine carcinosarcomas.
Taylor NP; Gibb RK; Powell MA; Mutch DG; Huettner PC; Goodfellow PJ
Gynecol Oncol; 2006 Jan; 100(1):107-10. PubMed ID: 16169065
[TBL] [Abstract][Full Text] [Related]
5. Impaired nonhomologous end-joining in mismatch repair-deficient colon carcinomas.
Koh KH; Kang HJ; Li LS; Kim NG; You KT; Yang E; Kim H; Kim HJ; Yun CO; Kim KS; Kim H
Lab Invest; 2005 Sep; 85(9):1130-8. PubMed ID: 16025146
[TBL] [Abstract][Full Text] [Related]
6. MSH2-deficient human cells exhibit a defect in the accurate termination of homology-directed repair of DNA double-strand breaks.
Villemure JF; Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2003 Jun; 63(12):3334-9. PubMed ID: 12810667
[TBL] [Abstract][Full Text] [Related]
7. Targeting DNA mismatch repair for radiosensitization.
Berry SE; Kinsella TJ
Semin Radiat Oncol; 2001 Oct; 11(4):300-15. PubMed ID: 11677655
[TBL] [Abstract][Full Text] [Related]
8. Effects of camptothecin on double-strand break repair by non-homologous end-joining in DNA mismatch repair-deficient human colorectal cancer cell lines.
Jacob S; Miquel C; Sarasin A; Praz F
Nucleic Acids Res; 2005; 33(1):106-13. PubMed ID: 15642697
[TBL] [Abstract][Full Text] [Related]
9. Common fragile sites in colon cancer cell lines: role of mismatch repair, RAD51 and poly(ADP-ribose) polymerase-1.
Vernole P; Muzi A; Volpi A; Terrinoni A; Dorio AS; Tentori L; Shah GM; Graziani G
Mutat Res; 2011 Jul; 712(1-2):40-8. PubMed ID: 21570414
[TBL] [Abstract][Full Text] [Related]
10. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance.
Lin X; Howell SB
Mol Cancer Ther; 2006 May; 5(5):1239-47. PubMed ID: 16731756
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of XRCC2 in homologous recombinational repair of stalled replication forks.
Liu N; Lim CS
J Cell Biochem; 2005 Aug; 95(5):942-54. PubMed ID: 15861395
[TBL] [Abstract][Full Text] [Related]
12. Human colon cancer cells surviving high doses of cisplatin or oxaliplatin in vitro are not defective in DNA mismatch repair proteins.
Sergent C; Franco N; Chapusot C; Lizard-Nacol S; Isambert N; Correia M; Chauffert B
Cancer Chemother Pharmacol; 2002 Jun; 49(6):445-52. PubMed ID: 12107548
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of homologous recombination DNA repair in alkylating agent-treated stem cell clones: a possible role in the aetiology of chemotherapy-induced leukaemia.
Worrillow LJ; Allan JM
Oncogene; 2006 Mar; 25(12):1709-20. PubMed ID: 16278672
[TBL] [Abstract][Full Text] [Related]
14. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination.
Johnson RD; Liu N; Jasin M
Nature; 1999 Sep; 401(6751):397-9. PubMed ID: 10517641
[TBL] [Abstract][Full Text] [Related]
15. The mismatch repair protein, hMLH1, mediates 5-substituted halogenated thymidine analogue cytotoxicity, DNA incorporation, and radiosensitization in human colon cancer cells.
Berry SE; Garces C; Hwang HS; Kunugi K; Meyers M; Davis TW; Boothman DA; Kinsella TJ
Cancer Res; 1999 Apr; 59(8):1840-5. PubMed ID: 10213489
[TBL] [Abstract][Full Text] [Related]
16. Loss of DNA mismatch repair imparts defective cdc2 signaling and G(2) arrest responses without altering survival after ionizing radiation.
Yan T; Schupp JE; Hwang HS; Wagner MW; Berry SE; Strickfaden S; Veigl ML; Sedwick WD; Boothman DA; Kinsella TJ
Cancer Res; 2001 Nov; 61(22):8290-7. PubMed ID: 11719462
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitivity to camptothecin in MSH2 deficient cells is correlated with a role for MSH2 protein in recombinational repair.
Pichierri P; Franchitto A; Piergentili R; Colussi C; Palitti F
Carcinogenesis; 2001 Nov; 22(11):1781-7. PubMed ID: 11698339
[TBL] [Abstract][Full Text] [Related]
18. Role of the DNA repair nucleases Rad13, Rad2 and Uve1 of Schizosaccharomyces pombe in mismatch correction.
Kunz C; Fleck O
J Mol Biol; 2001 Oct; 313(2):241-53. PubMed ID: 11800554
[TBL] [Abstract][Full Text] [Related]
19. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
Yan T; Berry SE; Desai AB; Kinsella TJ
Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair deficiency in hematological malignancies with microsatellite instability.
Gu L; Cline-Brown B; Zhang F; Qiu L; Li GM
Oncogene; 2002 Aug; 21(37):5758-64. PubMed ID: 12173046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
